Your browser doesn't support javascript.
loading
Cardiac Safety of Imatinib for the Treatment of COVID-19: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial.
Duijvelaar, Erik; Vanhove, Arthur; Schippers, Job R; Smeele, Patrick J; de Man, Frances S; Pinto, Yigal; Aman, Jurjan; Bogaard, Harm Jan.
Afiliación
  • Duijvelaar E; Amsterdam UMC, location VUMC, Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, Netherlands; and.
  • Vanhove A; Amsterdam UMC, location VUMC, Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, Netherlands; and.
  • Schippers JR; Amsterdam UMC, location VUMC, Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, Netherlands; and.
  • Smeele PJ; Amsterdam UMC, location VUMC, Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, Netherlands; and.
  • de Man FS; Amsterdam UMC, location VUMC, Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, Netherlands; and.
  • Pinto Y; Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Heart Center, Department of Clinical and Experimental Cardiology.
  • Aman J; Amsterdam UMC, location VUMC, Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, Netherlands; and.
  • Bogaard HJ; Amsterdam UMC, location VUMC, Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, Netherlands; and.
J Cardiovasc Pharmacol ; 80(6): 783-791, 2022 12 01.
Article en En | MEDLINE | ID: mdl-35976136
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / COVID-19 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: J Cardiovasc Pharmacol Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / COVID-19 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: J Cardiovasc Pharmacol Año: 2022 Tipo del documento: Article